ResearcherThird Affiliated Hospital of Guangzhou Medical UniversityActive in the last 2 years
Fangquan Chen
Matched on ORCID iD 0009-0004-1244-8731; OpenAlex author ID A5026866445. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2024: 2 papers · 2025: 3 papers · 2026: 1 paper
Papers 6
- Ferroptosis at the intersection of metabolism and immunity in pancreatitis and pancreatic cancer. Co-author DOI 10.1016/j.smim.2026.102049↗
- CYP51A1 drives resistance to pH-dependent cell death in pancreatic cancer. Co-author DOI 10.1038/s41467-025-57583-2↗
- AGER-dependent macropinocytosis drives resistance to KRAS-G12D-targeted therapy in advanced pancreatic cancer. Co-author DOI 10.1126/scitranslmed.adp4986↗
- Cryptotanshinone differentially induces cell death in ATP6V0D1-deficient pancreatic cancer cells. Co-author DOI 10.20517/cdr.2025.103↗
- ITCH inhibits alkaliptosis in human pancreatic cancer cells through YAP1-dependent SLC16A1 activation. First author DOI 10.1016/j.biocel.2024.106646↗
- Macropinocytosis inhibits alkaliptosis in pancreatic cancer cells through fatty acid uptake. Co-author DOI 10.1093/carcin/bgae045↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jiao Liu · 6 shared papers, 2024–2026 · strength 1.65
- Paper Ferroptosis at the intersection of metabolism and immunity in pancreatitis and pancreatic cancer. DOI 10.1016/j.smim.2026.102049↗
- Paper CYP51A1 drives resistance to pH-dependent cell death in pancreatic cancer. DOI 10.1038/s41467-025-57583-2↗
- Paper AGER-dependent macropinocytosis drives resistance to KRAS-G12D-targeted therapy in advanced pancreatic cancer. DOI 10.1126/scitranslmed.adp4986↗
- Daolin Tang · 5 shared papers, 2024–2025 · strength 1.26
- Paper CYP51A1 drives resistance to pH-dependent cell death in pancreatic cancer. DOI 10.1038/s41467-025-57583-2↗
- Paper AGER-dependent macropinocytosis drives resistance to KRAS-G12D-targeted therapy in advanced pancreatic cancer. DOI 10.1126/scitranslmed.adp4986↗
- Paper Cryptotanshinone differentially induces cell death in ATP6V0D1-deficient pancreatic cancer cells. DOI 10.20517/cdr.2025.103↗
- Xiutao Cai · 3 shared papers, 2024–2026 · strength 0.87
- Paper Ferroptosis at the intersection of metabolism and immunity in pancreatitis and pancreatic cancer. DOI 10.1016/j.smim.2026.102049↗
- Paper Cryptotanshinone differentially induces cell death in ATP6V0D1-deficient pancreatic cancer cells. DOI 10.20517/cdr.2025.103↗
- Paper ITCH inhibits alkaliptosis in human pancreatic cancer cells through YAP1-dependent SLC16A1 activation. DOI 10.1016/j.biocel.2024.106646↗
- Rui Kang · 3 shared papers, 2025 · strength 0.79
- Paper CYP51A1 drives resistance to pH-dependent cell death in pancreatic cancer. DOI 10.1038/s41467-025-57583-2↗
- Paper AGER-dependent macropinocytosis drives resistance to KRAS-G12D-targeted therapy in advanced pancreatic cancer. DOI 10.1126/scitranslmed.adp4986↗
- Paper Cryptotanshinone differentially induces cell death in ATP6V0D1-deficient pancreatic cancer cells. DOI 10.20517/cdr.2025.103↗
- Changfeng Li · 2 shared papers, 2025 · strength 0.55
- Yuanda Liu · 1 shared paper, 2025 · strength 0.25
- Yangchun Xie · 1 shared paper, 2025 · strength 0.25
- Herbert J. Zeh · 1 shared paper, 2025 · strength 0.25
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.